|
|
||||||||
From the Laboratory of Germfree Animal Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014
Abstract
The suppressive effects of anti-lymphoid serum upon the capacity of mouse spleen cells to mediate graft-vs.-host reactions was measured quantitatively using a spleen assay. Changes in cellular reactivity with time after treatment were measured using a parallel line method. When spleen cells were assayed 2 days after a single injection of anti-thymocyte serum at least a 12-fold suppression in cellular reactivity was noted. Considerable suppression was found after 6 days (ninefold) and 14 days (fivefold) while by day 28 a return toward normal function was evident. A series of four ATS doses resulted in a more severe suppression when cells were tested after 1, 8 and 15 days, but by day 28 the reaction again approached normal.
The administration of smaller quantities of anti-thymocyte serum resulted in a proportionally less suppressed state. With each decrease in antiserum dose an approximately proportionate decrease in suppression of GVH was observed.
Rabbit antisera produced against BALB/cAnN thymocytes caused a diminution in the reactivity of C57BL/6J spleen cells. The degree of suppression was of approximately the same intensity as seen with spleen cells from similarly treated BALB/cAnN mice.
There was an apparent correlation between the ability of ATS to delay rejection of skin grafts and its ability to modify the graft-vs.-host reaction. It appeared that at least a 10-fold level of suppression was required to prolong skin graft survival.
Footnotes
1 Present address: Department of Surgery, University Hospitals of Cleveland, Cleveland, Ohio 44106.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |